LeMaitre Vascular Inc
NASDAQ:LMAT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
54
107.97
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
LeMaitre Vascular Inc
Wall Street
Price Targets
LMAT Price Targets Summary
LeMaitre Vascular Inc
According to Wall Street analysts, the average 1-year price target for
LMAT
is 101.43 USD
with a low forecast of 85.85 USD and a high forecast of 122.85 USD.
LMAT Last Price Targets
LeMaitre Vascular Inc
The latest public price target was made on Oct 15, 2024 by
Ross Osborn
from
Cantor Fitzgerald
,
who expects
LMAT
stock to
rise by 3%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Ross Osborn
Cantor Fitzgerald
|
96
USD
Upside 3% |
2 months ago
Oct 15, 2024
|
LeMaitre initiated with a Neutral at Cantor Fitzgerald
TheFly
|
Daniel Stauder
JMP Securities
|
100
USD
Upside 8% |
4 months ago
Aug 20, 2024
|
LeMaitre price target raised to $100 from $77 at JMP Securities
TheFly
|
Rick Wise
Stifel Nicolaus
|
75
USD
Downside 19% |
8 months ago
Apr 26, 2024
|
Stifel Upgrades LeMaitre Vascular (LMAT) to Buy
StreetInsider
|
Suraj Kalia
Oppenheimer
|
70
USD
Downside 25% |
1 year ago
Sep 6, 2023
|
Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating
Benzinga
|
Price Targets
Operating Income
Forecast
Operating Income Estimate
LeMaitre Vascular Inc
For the last 8 years the
compound annual growth rate for
LeMaitre Vascular Inc's operating income is
16%.
The projected
CAGR
for the next 4 years is
20%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LMAT's stock price target?
Price Target
101.43
USD
According to Wall Street analysts, the average 1-year price target for
LMAT
is 101.43 USD
with a low forecast of 85.85 USD and a high forecast of 122.85 USD.
What is LeMaitre Vascular Inc's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
LeMaitre Vascular Inc's revenue is
12%.
The projected
CAGR
for the next 4 years is
11%.
What is LeMaitre Vascular Inc's Operating Income forecast?
Projected CAGR
20%
For the last 8 years the
compound annual growth rate for
LeMaitre Vascular Inc's operating income is
16%.
The projected
CAGR
for the next 4 years is
20%.
What is LeMaitre Vascular Inc's Net Income forecast?
Projected CAGR
19%
For the last 8 years the
compound annual growth rate for
LeMaitre Vascular Inc's net income is
18%.
The projected
CAGR
for the next 4 years is
19%.
You don't have any saved screeners yet
